Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Tasosartan international status updated

April 22, 1998

Endothelin antagonists discovered at Ajinomoto

April 22, 1998

Clinical trial of gene therapy to stimulate angiogenesis in angina patients

April 22, 1998

Sanofi discloses cGMP PDE inhibitors for cardiovascular indications

April 21, 1998

Mechanisms mediating the effects of ADM on cardiac contractility

April 21, 1998

Cardiovascular gene therapy focus of Cell Genesys-Mitotix agreement

April 20, 1998

New endothelin antagonists from Bristol-Myers Squibb

April 20, 1998

FDA requests additional information for CP-Cardiosol IND

April 17, 1998

ICAgen and Lilly disclose potassium channel inhibitors

April 17, 1998

Another market introduction for irbesartan

April 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...